Conference
ORAL01.03: CheckMate 012: Safety and Efficacy of First-Line Nivolumab and Ipilimumab in Advanced NSCLC Topic: Medical Oncology
Authors
Antonia SJ; Gettinger SN; Goldman J; Brahmer J; Borghaei H; Chow LQ; Ready NE; Gerber DE; Juergens R; Shepherd F
Volume
11
Pagination
pp. s250-s251
Publisher
Elsevier
Publication Date
11 2016
DOI
10.1016/j.jtho.2016.09.008
Conference proceedings
Journal of Thoracic Oncology
Issue
11
ISSN
1556-0864